To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children

Completed · Not applicable

Conditions studied: Atopic Dermatitis

In brief

The purpose of this study was to evaluate the safety of the investigational study product and see how well it works to relieve signs and symptoms of children with mild to moderate Atopic Dermatitis (AD), also known as eczema, in comparison to that of a similar marketed product. This study was conducted to assess the safety of the investigational new study product and how well it works to treat AD in children, by making AD visually better, and reducing the amount of itch.

Key facts

Study ID

NCT00886587

Run by

Johnson & Johnson Consumer and Personal Products Worldwide

People needed

82

Starts

2009-04-01

Expected to finish

2009-06-01

Last updated by the study team

2017-05-23

Who can join

Age: 2 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Post-menarchal female subjects must have a negative urine pregnancy test
• Willing to provide written informed consent/assent
• Diagnosed as having mild to moderate Atopic Dermatitis (AD)
• Willing to stop all moisturizers and/or other skin barrier cream or emulsion treatments for the AD condition during the test period and replace with the investigational product assigned in this trial
• Willing to replace their body wash and/or soaps with the one provided in this trial

You may not qualify if…

• Severe AD as determined by the Rajka-Langeland Severity Index
• AD requiring systemic, super-potent (Class I) or potent (Class II or III) topical corticosteroids. If the subject requires any of these medications as rescue therapy during the study, the subject will be discontinued from the trial
• History of allergy or hypersensitivity to the ingredients of the test devices, nuts or nut oil
• Cutaneous or systemic viral (including HIV or AIDS), mycotic or bacterial disease requiring a topical or systemic therapy
• Diabetes mellitus that cannot be controlled by diet alone (i.e., requires systemic medications for control)

Where it is running

• Thomas J. Stephens & Associates, Inc — Colorado Springs, Colorado, United States
• Academic Dermatology Associates — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.